Literature DB >> 29437127

Kawasaki Disease.

Mary Beth F Son1, Jane W Newburger2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29437127     DOI： 10.1542/pir.2016-0182

Source DB:  PubMed          Journal:  Pediatr Rev        ISSN： 0191-9601


× No keyword cloud information.
  12 in total

1.  Primary care approach to Kawasaki disease.

Authors:  Joanne Mui Ching Tan; Jeanette Keng Wein Tan; Choon How How; Kai Liang Teh
Journal:  Singapore Med J       Date:  2021-01       Impact factor: 1.858

2.  Intravenous Immunoglobulin Nonresponse in Pediatric Patients Treated for Kawasaki Disease at a US Hospital.

Authors:  Lauryn Smelser; Jennifer Vejzovic; Emma Johnson; Jordan Schultz; Kelly E Wood
Journal:  J Pediatr Pharmacol Ther       Date:  2022-02-09

3.  Incomplete Kawasaki Disease in a Child with Covid-19.

Authors:  Elvia I Rivera-Figueroa; Roberto Santos; Scott Simpson; Padma Garg
Journal:  Indian Pediatr       Date:  2020-05-09       Impact factor: 1.411

4.  Kawasaki disease recognition and treatment.

Authors:  Kimberly A Morishita; Ran D Goldman
Journal:  Can Fam Physician       Date:  2020-08       Impact factor: 3.275

5.  Circulating adipokines are associated with Kawasaki disease.

Authors:  Xin-Yan Zhang; Ting-Ting Yang; Xiu-Fen Hu; Yu Wen; Feng Fang; Hui-Ling Lu
Journal:  Pediatr Rheumatol Online J       Date:  2018-05-08       Impact factor: 3.054

6.  Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011-2016): KAWA-RACE study group.

Authors:  Elisa Fernandez-Cooke; Ana Barrios Tascón; Judith Sánchez-Manubens; Jordi Antón; Carlos Daniel Grasa Lozano; Javier Aracil Santos; Enrique Villalobos Pinto; Daniel Clemente Garulo; Beatriz Mercader Rodríguez; Matilde Bustillo Alonso; Esmeralda Nuñez Cuadros; Maria Luisa Navarro Gómez; Sara Domínguez-Rodríguez; Cristina Calvo
Journal:  PLoS One       Date:  2019-05-20       Impact factor: 3.240

7.  Breastfeeding and vitamin D supplementation reduce the risk of Kawasaki disease in a German population-based case-control study.

Authors:  K Meyer; A Volkmann; M Hufnagel; E Schachinger; S Klau; J Horstmann; R Berner; M Fischer; A Lehner; N Haas; S Ulrich; A Jakob
Journal:  BMC Pediatr       Date:  2019-02-26       Impact factor: 2.125

Review 8.  The importance of heart and brain imaging in children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C).

Authors:  Sophie I Mavrogeni; Genovefa Kolovou; Vasileios Tsirimpis; Dimitrios Kafetzis; Georgios Tsolas; Lampros Fotis
Journal:  Rheumatol Int       Date:  2021-04-17       Impact factor: 2.631

Review 9.  SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?

Authors:  Vanessa Sancho-Shimizu; Petter Brodin; Aurélie Cobat; Catherine M Biggs; Julie Toubiana; Carrie L Lucas; Sarah E Henrickson; Alexandre Belot; Stuart G Tangye; Joshua D Milner; Michael Levin; Laurent Abel; Dusan Bogunovic; Jean-Laurent Casanova; Shen-Ying Zhang
Journal:  J Exp Med       Date:  2021-06-07       Impact factor: 14.307

Review 10.  Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach.

Authors:  Francesca Sperotto; Kevin G Friedman; Mary Beth F Son; Christina J VanderPluym; Jane W Newburger; Audrey Dionne
Journal:  Eur J Pediatr       Date:  2020-08-15       Impact factor: 3.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.